-
Vafseo® approved by the U.S. FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients
28 Mar 2024 11:19 GMT
… Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment … manufacturing and marketing pharmaceutical products for … also increase erythropoietin levels.
No trial has identified … reduction.
Statins: Monitor for statin-related adverse …
-
Akebia’s Vafseo gains FDA approval for anaemia due to CKD
28 Mar 2024 11:20 GMT
The US Food and Drug Administration (FDA) has approved Akebia Therapeutics … stimulate the production of erythropoietin.
Vafseo’s approval in … its partnership with speciality pharmaceuticals company CSL Vifor, … to deliver an alternative treatment option for the …
-
FDA Approves For Akebia Therapeutics' Vafseo For Kidney Disease Associated Anemia
28 Mar 2024 14:42 GMT
Wednesday, the FDA approved Akebia Therapeutics … to stimulate endogenous production of erythropoietin to manage anemia.
Vafseo … the New England Journal of Medicine.
Approximately 500,000 adult … ’ Kidney Disease-Associated Anemia Drug, Stock Soars.
Citing, H …
-
Akebia's Vafseo Tablets Approved By FDA For Anemia Treatment In Dialysis Patients
28 Mar 2024 02:31 GMT
… and Drug Administration has approved Vafseo or vadadustat Tablets for the treatment … to stimulate endogenous production of erythropoietin to manage anemia. Vafseo is …
-
Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
28 Mar 2024 01:37 GMT
… Drug Administration (FDA) has approved Vafseo® (vadadustat) Tablets for the treatment … also increase erythropoietin levels.
No trial has identified … dose reduction.
Statins: Monitor for statin-related adverse … BOXED WARNING and Medication Guide.
Forward- …
-
Government investigates doctors for using expired medicines in Aleppo
27 Mar 2024 20:34 GMT
… involved in forging some pharmaceutical groups, issuing fake medical bills, and illegally … , blood type incompatibility drugs, erythropoietin, and cancer treatment drugs.
The Doctors Syndicate did not comment …
-
Investigation of Potential Toxic Effects of Engineered Nanoparticles and Biologic Microparticles in Blood and Their Biomarker Applications
26 Mar 2024 23:43 GMT
… CBER representative in the FDA Nanotechnology Taskforce.
General Overview … nanomaterials being applied for medical use. In addition, … are employed in developing drug delivery systems or vaccines. … and dose of an erythropoietin peptide mimetic product are …
-
Immune Dysfunction-Associated Elevated RDW, APACHE-II, and SOFA Scores Were a Possible Cause of 28-Day Mortality in Sepsis Patients
26 Mar 2024 10:51 GMT
… homeostasis and resistance to erythropoietin. The association between … monitoring indicators and treatment targets for different subgroups … accurate diagnosis and treatment for sepsis patients … medical staff of the ICU for the diagnosis and treatment …
-
Joint effort turning tide against doping menace
24 Mar 2024 20:36 GMT
… by moving from the common Erythropoietin (EPO) to a new special … from unfair competition domestically from drug cheats.
“I am glad to …
-
Submit Periodic Safety Update Report In Indian Population: CDSCO Panel Tells Intas on rHumanErythropoeitinalfa injection
22 Mar 2024 22:17 GMT
… came after the drug maker Intas Pharmaceutical presented the proposal … to cancer or its treatment.
Erythropoietin is a recombinant form … cells in the treatment of anemia. Erythropoietin (EPO) is … is caused by surgery or medicines (eg, zidovudine) that …